Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth Carl Anderson currently holds 68,230 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth Carl Anderson has been a net neutral trader of CCCC stock. They have purchased $0 and sold $0 worth of shares.
Kenneth Carl Anderson's most recent insider trade was on Apr 1, 2026, when they sold 4,259 shares at $2.70 per share.
Kenneth Carl Anderson serves as Executive at C4 Therapeutics, Inc. (CCCC). They have executed 38 insider transactions totaling $0 over their tenure at the company.
Kenneth Carl Anderson holds the position of Executive at C4 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Kenneth Carl Anderson has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Kenneth Carl Anderson was on Oct 1, 2025, when they purchased $11.5K worth of CCCC shares. This transaction involved 5,349 shares at $2.15 per share.
Kenneth Carl Anderson currently owns 68,230 shares of C4 Therapeutics, Inc. (CCCC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth Carl Anderson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth Carl Anderson has 38 Form 4 filings on record as an insider at C4 Therapeutics, Inc..
Set alerts for Kenneth Carl Anderson and 40,000+ other insiders.